This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Sandro Girolami: Innovator in Blood Glucose Measurement Technology
Introduction
Sandro Girolami is a notable inventor based in San Benedetto del Tronto, Italy. He has made significant contributions to the field of medical technology, particularly in the area of blood glucose measurement. His innovative work aims to improve the accuracy and reliability of glucose monitoring for individuals with diabetes.
Latest Patents
Sandro Girolami holds a patent for a "Pattern recognition engine for blood glucose measurements." This patent relates to systems, methods, and apparatus for recognizing patterns in blood glucose measurements. The invention involves a computer-implemented blood glucose analysis method that includes receiving multiple blood glucose measurements taken over various temporal frames. It identifies hypoglycaemic and/or hyperglycaemic measurements, infers temporal relationships between these measurements, and outputs suggested causal drivers for the inferred relationships. This patent represents a significant advancement in the management of blood glucose levels.
Career Highlights
Sandro Girolami is currently employed at Sanofi, a global healthcare company known for its commitment to innovation in pharmaceuticals and biotechnology. His work at Sanofi allows him to collaborate with other experts in the field and contribute to the development of cutting-edge medical technologies.
Collaborations
Sandro has worked alongside talented colleagues such as Giacomo Vespasiani and Milena Saleh. Their collaborative efforts have fostered an environment of innovation and creativity, leading to advancements in medical technology.
Conclusion
Sandro Girolami's contributions to blood glucose measurement technology exemplify the impact of innovation in healthcare. His patent for a pattern recognition engine is a testament to his dedication to improving the lives of individuals managing diabetes. Through his work at Sanofi and collaborations with fellow experts, Girolami continues to push the boundaries of medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile